Skip to content

Clinical trials

Completed Phase 1/2 Rare Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rare Diseases Phase: Phase 1/2 Status: Completed Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20132
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)5
Amgen1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Fred Hutchinson Cancer Center1
Italfarmaco1
Klus Pharma Inc.1
Minovia Therapeutics Ltd.1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Ultragenyx Pharmaceutical Inc1
University of North Carolina1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rare Diseases14
Communicable Diseases3
Hematologic Diseases3
Immune System Diseases3
Anemia, Sickle Cell2
Genetic Diseases, Inborn2
Herpesviridae Infections2
Metabolism, Inborn Errors2
Virus Diseases2
Bile Duct Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.